• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性 T 细胞的代谢特征及其对肿瘤微环境的适应:对抗肿瘤免疫的影响。

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity.

机构信息

Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

出版信息

J Hematol Oncol. 2022 Aug 10;15(1):104. doi: 10.1186/s13045-022-01322-3.

DOI:10.1186/s13045-022-01322-3
PMID:35948909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9364625/
Abstract

Characterized by the expression of the critical transcription factor forkhead box protein P3, regulatory T (Treg) cells are an essential part of the immune system, with a dual effect on the pathogenesis of autoimmune diseases and cancer. Targeting Tregs to reestablish the proinflammatory and immunogenic tumor microenvironment (TME) is an increasingly attractive strategy for cancer treatment and has been emphasized in recent years. However, attempts have been significantly hindered by the subsequent autoimmunity after Treg ablation owing to systemic loss of their suppressive capacity. Cellular metabolic reprogramming is acknowledged as a hallmark of cancer, and emerging evidence suggests that elucidating the underlying mechanisms of how intratumoral Tregs acquire metabolic fitness and superior immunosuppression in the TME may contribute to clinical benefits. In this review, we discuss the common and distinct metabolic profiles of Tregs in peripheral tissues and the TME, as well as the differences between Tregs and other conventional T cells in their metabolic preferences. By focusing on the critical roles of different metabolic programs, such as glycolysis, oxidative phosphorylation, fatty acid oxidation, fatty acid synthesis, and amino acid metabolism, as well as their essential regulators in modulating Treg proliferation, migration, and function, we hope to provide new insights into Treg cell-targeted antitumor immunotherapies.

摘要

特征在于关键转录因子叉头框蛋白 P3 的表达,调节性 T(Treg)细胞是免疫系统的重要组成部分,对自身免疫性疾病和癌症的发病机制具有双重影响。靶向 Treg 以重新建立促炎和免疫原性肿瘤微环境(TME)是癌症治疗的一种越来越有吸引力的策略,近年来已得到强调。然而,由于系统性丧失其抑制能力,Treg 消融后随后发生自身免疫,这一尝试受到了显著阻碍。细胞代谢重编程被认为是癌症的标志,新出现的证据表明,阐明肿瘤内 Treg 在 TME 中获得代谢适应性和卓越免疫抑制作用的潜在机制可能有助于临床获益。在这篇综述中,我们讨论了外周组织和 TME 中 Treg 的常见和独特代谢特征,以及 Treg 在代谢偏好方面与其他常规 T 细胞的区别。通过关注不同代谢程序(如糖酵解、氧化磷酸化、脂肪酸氧化、脂肪酸合成和氨基酸代谢)以及调节 Treg 增殖、迁移和功能的关键调节剂的关键作用,我们希望为 Treg 细胞靶向抗肿瘤免疫疗法提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57a/9364625/5553b4b65709/13045_2022_1322_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57a/9364625/71a03cf30f99/13045_2022_1322_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57a/9364625/790aa2f90f2d/13045_2022_1322_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57a/9364625/ac7ba649860f/13045_2022_1322_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57a/9364625/b870f1600e3d/13045_2022_1322_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57a/9364625/5553b4b65709/13045_2022_1322_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57a/9364625/71a03cf30f99/13045_2022_1322_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57a/9364625/790aa2f90f2d/13045_2022_1322_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57a/9364625/ac7ba649860f/13045_2022_1322_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57a/9364625/b870f1600e3d/13045_2022_1322_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57a/9364625/5553b4b65709/13045_2022_1322_Fig5_HTML.jpg

相似文献

1
Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity.调节性 T 细胞的代谢特征及其对肿瘤微环境的适应:对抗肿瘤免疫的影响。
J Hematol Oncol. 2022 Aug 10;15(1):104. doi: 10.1186/s13045-022-01322-3.
2
Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.癌症中调节性T细胞的代谢调控:免疫治疗的机遇
Trends Cancer. 2017 Aug;3(8):583-592. doi: 10.1016/j.trecan.2017.06.005. Epub 2017 Jul 14.
3
Treg Fragility: A Prerequisite for Effective Antitumor Immunity?调节性 T 细胞脆弱性:抗肿瘤免疫的必要条件?
Cancer Immunol Res. 2018 Aug;6(8):882-887. doi: 10.1158/2326-6066.CIR-18-0066.
4
Metabolic profiles of regulatory T cells in the tumour microenvironment.肿瘤微环境中调节性 T 细胞的代谢特征。
Cancer Immunol Immunother. 2021 Sep;70(9):2417-2427. doi: 10.1007/s00262-021-02881-z. Epub 2021 Feb 12.
5
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.缺氧肿瘤微环境中 T 调节细胞的代谢重编程。
Cancer Immunol Immunother. 2021 Aug;70(8):2103-2121. doi: 10.1007/s00262-020-02842-y. Epub 2021 Feb 3.
6
Expression of costimulatory and inhibitory receptors in FoxP3 regulatory T cells within the tumor microenvironment: Implications for combination immunotherapy approaches.肿瘤微环境中 FoxP3 调节性 T 细胞中共刺激和共抑制受体的表达:对联合免疫治疗方法的影响。
Adv Cancer Res. 2019;144:193-261. doi: 10.1016/bs.acr.2019.05.001. Epub 2019 Jun 6.
7
A Metabolic Gene Survey Pinpoints Fucosylation as a Key Pathway Underlying the Suppressive Function of Regulatory T Cells in Cancer.代谢基因研究表明岩藻糖基化是调节性 T 细胞在肿瘤中抑制功能的关键途径。
Cancer Immunol Res. 2023 Dec 1;11(12):1611-1629. doi: 10.1158/2326-6066.CIR-22-0606.
8
Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.肿瘤内干细胞样 CCR4+ 调节性 T 细胞协调乙型肝炎相关 HCC 的免疫抑制微环境。
J Hepatol. 2022 Jan;76(1):148-159. doi: 10.1016/j.jhep.2021.08.029. Epub 2021 Sep 12.
9
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.调节性 T 细胞浸润肿瘤的机制:对创新免疫精准治疗的启示。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002591.
10
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors.CD36 介导的代谢适应支持调节性 T 细胞在肿瘤中的存活和功能。
Nat Immunol. 2020 Mar;21(3):298-308. doi: 10.1038/s41590-019-0589-5. Epub 2020 Feb 17.

引用本文的文献

1
The impact of aberrant lipid metabolism on the immune microenvironment of gastric cancer: a mini review.异常脂质代谢对胃癌免疫微环境的影响:一篇综述
Front Immunol. 2025 Aug 18;16:1639823. doi: 10.3389/fimmu.2025.1639823. eCollection 2025.
2
Metabolic Reprogramming Shapes the Progression and Therapeutic Landscape of Ovarian Cancer.代谢重编程塑造卵巢癌的进展和治疗格局。
Cancer Manag Res. 2025 Aug 19;17:1707-1722. doi: 10.2147/CMAR.S538281. eCollection 2025.
3
Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications.

本文引用的文献

1
Retinoic acid signaling acts as a rheostat to balance Treg function.视黄酸信号作为变阻器来平衡 Treg 功能。
Cell Mol Immunol. 2022 Jul;19(7):820-833. doi: 10.1038/s41423-022-00869-y. Epub 2022 May 17.
2
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.乳酸在高度糖酵解的肿瘤微环境中促进调节性 T 细胞中 PD-1 的表达。
Cancer Cell. 2022 Feb 14;40(2):201-218.e9. doi: 10.1016/j.ccell.2022.01.001. Epub 2022 Jan 28.
3
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions.
探索铁死亡在食管癌中的作用:机制与治疗意义
Cell Death Discov. 2025 Aug 25;11(1):405. doi: 10.1038/s41420-025-02696-2.
4
Biomechanics of the tumor extracellular matrix and regulatory T cells: regulatory mechanisms and potential therapeutic targets.肿瘤细胞外基质与调节性T细胞的生物力学:调节机制与潜在治疗靶点
Cell Commun Signal. 2025 Aug 21;23(1):375. doi: 10.1186/s12964-025-02380-z.
5
The Streptomyces Metabolite Thiostrepton Inhibits Regulatory T Cell Differentiation and Function to Boost Antitumor Immune Responses.链霉菌代谢产物硫链丝菌素可抑制调节性T细胞的分化和功能,从而增强抗肿瘤免疫反应。
Eur J Immunol. 2025 Aug;55(8):e70035. doi: 10.1002/eji.70035.
6
Dysfunction and Metabolic Reprogramming of Gut Regulatory T Cells in HIV-Infected Immunological Non-Responders.HIV感染的免疫无应答者肠道调节性T细胞的功能障碍与代谢重编程
Cells. 2025 Jul 29;14(15):1164. doi: 10.3390/cells14151164.
7
Dysregulated Cholesterol Metabolism and Its Impact on the Tumour Immune Response in Colorectal Cancer.胆固醇代谢失调及其对结直肠癌肿瘤免疫反应的影响
J Cell Mol Med. 2025 Aug;29(15):e70789. doi: 10.1111/jcmm.70789.
8
Mechanisms of T-cell metabolic reprogramming in the microenvironment of acute myeloid leukemia and its therapeutic potential (Review).急性髓系白血病微环境中T细胞代谢重编程的机制及其治疗潜力(综述)
Oncol Lett. 2025 Jul 22;30(4):455. doi: 10.3892/ol.2025.15201. eCollection 2025 Oct.
9
Role of the TLR signaling pathway in the pathogenesis of glioblastoma multiforme with an emphasis on immunotherapy.Toll样受体(TLR)信号通路在多形性胶质母细胞瘤发病机制中的作用,重点在于免疫治疗。
Biochem Biophys Rep. 2025 Jul 18;43:102149. doi: 10.1016/j.bbrep.2025.102149. eCollection 2025 Sep.
10
Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies.解码肿瘤微环境中的代谢对话:从免疫抑制到精准癌症治疗
Exp Hematol Oncol. 2025 Jul 22;14(1):99. doi: 10.1186/s40164-025-00689-6.
PD-1/PD-L1 阻断的联合策略:当前进展和未来方向。
Mol Cancer. 2022 Jan 21;21(1):28. doi: 10.1186/s12943-021-01489-2.
4
Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies.肿瘤相关巨噬细胞在肿瘤进展中的作用:对治疗策略的启示
Exp Hematol Oncol. 2021 Dec 29;10(1):60. doi: 10.1186/s40164-021-00252-z.
5
Contradictory roles of lipid metabolism in immune response within the tumor microenvironment.脂质代谢在肿瘤微环境中的免疫反应中的矛盾作用。
J Hematol Oncol. 2021 Nov 6;14(1):187. doi: 10.1186/s13045-021-01200-4.
6
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.泛 PI3K 抑制与免疫检查点阻断在膀胱癌中的协同抗肿瘤活性。
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-002917.
7
Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers.肿瘤相关巨噬细胞失调在妇科和乳腺癌的发生、发展及靶向治疗中的作用。
J Hematol Oncol. 2021 Oct 30;14(1):181. doi: 10.1186/s13045-021-01198-9.
8
Targeting CD47 for cancer immunotherapy.针对 CD47 的癌症免疫疗法。
J Hematol Oncol. 2021 Oct 30;14(1):180. doi: 10.1186/s13045-021-01197-w.
9
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy.肿瘤免疫治疗中髓源性抑制细胞的概况
Biomark Res. 2021 Oct 24;9(1):77. doi: 10.1186/s40364-021-00333-5.
10
Mechanistic Insight into PPARγ and Tregs in Atherosclerotic Immune Inflammation.对动脉粥样硬化免疫炎症中PPARγ和调节性T细胞的机制性见解。
Front Pharmacol. 2021 Sep 29;12:750078. doi: 10.3389/fphar.2021.750078. eCollection 2021.